[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Tony S. K. Mok<\/i><\/u><\/presenter>. Chinese Univ. of Hong Kong, Shatin, NT, Hong Kong","CSlideId":"","ControlKey":"0ca5e208-a526-4ad0-8699-c2b0d092f218","ControlNumber":"577","DisclosureBlock":"&nbsp;<b>&nbsp;T.S.K. Mok:<\/b>  ; ACEA Pharma. ; AVEO Pharmaceuticals, Inc. ; AbbVie Inc.. ; Adagene. ; Alentis Therapeutics AG. ; Alpha Biopharma Co., Ltd. ; Amgen. ; Amoy Diagnostics. ; AstraZeneca. ; AstraZeneca PLC. ; Aurora Tele-Oncology Ltd. ; Bayer Healthcare Pharmaceuticals Ltd. ; BeiGene, Ltd.. ; BerGenBio ASA. ; Berry Oncology. ; Biolidics Ltd. ; Blueprint Medicines Corporation. ; Boehringer Ingelheim. ; Bowtie Life Insurance Co. Ltd. ; Bridge Biotherapeutics Inc. ; Bristol-Myers Squibb. ; C4 Therapeutics Inc. ; CStone Pharmaceuticals. ; Cirina Ltd. ; Covidien LP. ; Curio Science. ; D3 Bio. ; Da Volterra. ; Daiichi Sankyo Company. ; Daz Group. ; Eisai. ; Elevation Oncology. ; Eli LIlly. ; F. Hoffmann-La Roche Ltd. ; Fishawack Facilitate Ltd. ; Foundation One. ; G1 Therapeutics Inc. ; GLG’s Healthcare. ; Genentech. ; Gilead Sciences, Inc.. ; Gritstone Oncology, Inc. ; Guardant Health. ; Hengrui Therapeutics Inc. ; HutchMed. ; IQVIA. ; Ignyta, Inc. ; Illumina, Inc.. ; Imagene AI Ltd. ; Incyte Corporation. ; Inivata. ; Insighta. ; Janssen Pharmaceuticals. ; Lakeshore Biotech Ltd. ; Liangyihui. ; Loxo-oncology. ; Lucence Health Inc. ; Lunit Inc. ; Medtronic. ; Merck Serono. ; Merck Sharp and Dohme. ; MiRXES. ; Mirati Therapeutics Inc. ; Novartis. ; Novocure GmbH. ; OSE Immunotherapeutics. ; Omega Therapeutics Inc. ; OrigiMed. ; PeerVoice. ; Pfizer. ; Phanes Therapeutics, Inc. ; Physicians’ Education Resource. ; PrIME Oncology. ; Prenetics. ; Puma Biotechnology Inc. ; Qiming Development (HK) Ltd. ; Regeneron Pharmaceuticals Inc. ; Roche. ; Roche Diagnostics GmbH. ; SFJ Pharmaceutical Ltd. ; Sanofi-Aventis. ; Shanghai Promedican Pharmaceuticals Co., Ltd.. ; Simcere of America Inc.. ; Summit Therapeutics Sub, Inc. ; Synergy Research. ; Taiho Pharmaceutical Co. Ltd. ; Takeda Oncology. ; Takeda Pharmaceuticals HK Ltd. ; Tigermed. ; Touch Independent Medical Education Ltd. ; Vertex Pharmaceuticals. ; Virtus Medical Group. ; XENCOR, Inc. ; Yuhan Corporation. ; Zai Lab. ; geneDecode Co., Ltd.","End":"4\/9\/2024 12:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"154","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Tony Mok","PresenterKey":"41bc7f69-1c68-42d2-8aed-a78fe13f57f0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024 12:30PM","SessionId":"125","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Deciphering Lung Cancer in Non-smokers - Dedicated to the Memory of Richard H. Creech","ShowChatLink":"false","Start":"4\/9\/2024 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Tony S. K. Mok<\/i><\/u><\/presenter>. Chinese Univ. of Hong Kong, Shatin, NT, Hong Kong","CSlideId":"","ControlKey":"8465577a-dd19-498d-b951-7703e2ce80d8","ControlNumber":"579","DisclosureBlock":"<b>&nbsp;T. S. K. Mok, <\/b> <br><b>ACEA Pharma<\/b> I. <br><b>AVEO Pharmaceuticals, Inc<\/b> I. <br><b>AbbVie Inc.<\/b> I, T. <br><b>Adagene<\/b> I. <br><b>Alentis Therapeutics AG<\/b> S. <br><b>Alpha Biopharma Co., Ltd<\/b> I. <br><b>Amgen<\/b> I. <br><b>Amoy Diagnostics<\/b> I. <br><b>AstraZeneca<\/b> I, S, T. <br><b>AstraZeneca PLC<\/b> I. <br><b>Aurora Tele-Oncology Ltd<\/b> I, S. <br><b>Bayer Healthcare Pharmaceuticals Ltd<\/b> I. <br><b>BeiGene, Ltd.<\/b> I. <br><b>BerGenBio ASA<\/b> I. <br><b>Berry Oncology<\/b> I. <br><b>Biolidics Ltd<\/b> S. <br><b>Blueprint Medicines Corporation<\/b> I. <br><b>Boehringer Ingelheim<\/b> I. <br><b>Bowtie Life Insurance Co. Ltd<\/b> I, S. <br><b>Bridge Biotherapeutics Inc<\/b> I. <br><b>Bristol-Myers Squibb<\/b> I. <br><b>C4 Therapeutics Inc<\/b> I. <br><b>CStone Pharmaceuticals<\/b> I. <br><b>Cirina Ltd<\/b> I. <br><b>Covidien LP<\/b> I. <br><b>Curio Science<\/b> I. <br><b>D3 Bio<\/b> I, S, S. <br><b>Da Volterra<\/b> I. <br><b>Daiichi Sankyo Company<\/b> I, T. <br><b>Daz Group<\/b> I. <br><b>Eisai<\/b> I. <br><b>Elevation Oncology<\/b> I. <br><b>Eli LIlly<\/b> I. <br><b>F. Hoffmann-La Roche Ltd<\/b> I. <br><b>Fishawack Facilitate Ltd<\/b> I. <br><b>Foundation One<\/b> I. <br><b>G1 Therapeutics Inc<\/b> I. <br><b>GLG’s Healthcare<\/b> I. <br><b>Genentech<\/b> I. <br><b>Gilead Sciences, Inc.<\/b> I. <br><b>Gritstone Oncology, Inc<\/b> I. <br><b>Guardant Health<\/b> I. <br><b>Hengrui Therapeutics Inc<\/b> I. <br><b>HutchMed<\/b> I, S. <br><b>IQVIA<\/b> I. <br><b>Ignyta, Inc<\/b> I. <br><b>Illumina, Inc.<\/b> I. <br><b>Imagene AI Ltd<\/b> I. <br><b>Incyte Corporation<\/b> I. <br><b>Inivata<\/b> I. <br><b>Insighta<\/b> S. <br><b>Janssen Pharmaceuticals<\/b> I. <br><b>Lakeshore Biotech Ltd<\/b> I, S. <br><b>Liangyihui<\/b> T. <br><b>Loxo-oncology<\/b> I, S. <br><b>Lucence Health Inc<\/b> I. <br><b>Lunit Inc<\/b> S. <br><b>Medtronic<\/b> I. <br><b>Merck Serono<\/b> I. <br><b>Merck Sharp and Dohme<\/b> I. <br><b>MiRXES<\/b> I, T. <br><b>Mirati Therapeutics Inc<\/b> I. <br><b>Novartis<\/b> I, T. <br><b>Novocure GmbH<\/b> I. <br><b>OSE Immunotherapeutics<\/b> I. <br><b>Omega Therapeutics Inc<\/b> I. <br><b>OrigiMed<\/b> I. <br><b>PeerVoice<\/b> I. <br><b>Pfizer<\/b> I, T. <br><b>Phanes Therapeutics, Inc<\/b> S. <br><b>Physicians’ Education Resource<\/b> I. <br><b>PrIME Oncology<\/b> I. <br><b>Prenetics<\/b> I, S. <br><b>Puma Biotechnology Inc<\/b> I. <br><b>Qiming Development (HK) Ltd<\/b> I. <br><b>Regeneron Pharmaceuticals Inc<\/b> I. <br><b>Roche<\/b> T. <br><b>Roche Diagnostics GmbH<\/b> I. <br><b>SFJ Pharmaceutical Ltd<\/b> I. <br><b>Sanofi-Aventis<\/b> I. <br><b>Shanghai Promedican Pharmaceuticals Co., Ltd.<\/b> I. <br><b>Simcere of America Inc.<\/b> I. <br><b>Summit Therapeutics Sub, Inc<\/b> I. <br><b>Synergy Research<\/b> I. <br><b>Taiho Pharmaceutical Co. Ltd<\/b> I. <br><b>Takeda Oncology<\/b> I. <br><b>Takeda Pharmaceuticals HK Ltd<\/b> I. <br><b>Tigermed<\/b> I. <br><b>Touch Independent Medical Education Ltd<\/b> I. <br><b>Vertex Pharmaceuticals<\/b> I. <br><b>Virtus Medical Group<\/b> I, S. <br><b>XENCOR, Inc<\/b> I. <br><b>Yuhan Corporation<\/b> I. <br><b>Zai Lab<\/b> T. <br><b>geneDecode Co., Ltd<\/b> I.","End":"4\/9\/2024 12:35:00 PM","HasWebcast":null,"Highlights":[],"Id":"156","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Tony Mok","PresenterKey":"41bc7f69-1c68-42d2-8aed-a78fe13f57f0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chair Introduction","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024 12:30PM","SessionId":"125","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Deciphering Lung Cancer in Non-smokers - Dedicated to the Memory of Richard H. Creech","ShowChatLink":"false","Start":"4\/9\/2024 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chair Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Elaine Shum<\/i><\/u><\/presenter>. NYU Langone Health Perlmutter Cancer Ctr., New York, NY","CSlideId":"","ControlKey":"bb73725f-5445-4d6d-a5df-de17e3fa7329","ControlNumber":"8994","DisclosureBlock":"<b>&nbsp;E. Shum, <\/b> <br><b>AstraZeneca<\/b> I. <br><b>Blueprint Medicines Corporation<\/b> I. <br><b>Boehringer Ingelheim<\/b> I. <br><b>Delfi Diagnostics<\/b> G. <br><b>Gilead Sciences, Inc.<\/b> I. <br><b>Regeneron Pharmaceuticals, Inc.<\/b> I.","End":"4\/9\/2024 1:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"441","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Elaine Shum, MD","PresenterKey":"4b9f0ca5-97ad-498d-a474-250423d78f68","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Screening for early stage lung cancer among never smoker: Can we? Should we?","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024 12:30PM","SessionId":"125","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Deciphering Lung Cancer in Non-smokers - Dedicated to the Memory of Richard H. Creech","ShowChatLink":"false","Start":"4\/9\/2024 12:35:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Screening for early stage lung cancer among never smoker: Can we? Should we?","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Tony S. K. Mok<\/i><\/u><\/presenter>. Chinese Univ. of Hong Kong, Shatin, NT, Hong Kong","CSlideId":"","ControlKey":"3245873f-609c-4b75-85ed-ecebbc45cb6b","ControlNumber":"9214","DisclosureBlock":"<b>&nbsp;T. S. K. Mok, <\/b> <br><b>ACEA Pharma<\/b> I. <br><b>AVEO Pharmaceuticals, Inc<\/b> I. <br><b>AbbVie Inc.<\/b> I, T. <br><b>Adagene<\/b> I. <br><b>Alentis Therapeutics AG<\/b> S. <br><b>Alpha Biopharma Co., Ltd<\/b> I. <br><b>Amgen<\/b> I. <br><b>Amoy Diagnostics<\/b> I. <br><b>AstraZeneca<\/b> I, S, T. <br><b>AstraZeneca PLC<\/b> I. <br><b>Aurora Tele-Oncology Ltd<\/b> I, S. <br><b>Bayer Healthcare Pharmaceuticals Ltd<\/b> I. <br><b>BeiGene, Ltd.<\/b> I. <br><b>BerGenBio ASA<\/b> I. <br><b>Berry Oncology<\/b> I. <br><b>Biolidics Ltd<\/b> S. <br><b>Blueprint Medicines Corporation<\/b> I. <br><b>Boehringer Ingelheim<\/b> I. <br><b>Bowtie Life Insurance Co. Ltd<\/b> I, S. <br><b>Bridge Biotherapeutics Inc<\/b> I. <br><b>Bristol-Myers Squibb<\/b> I. <br><b>C4 Therapeutics Inc<\/b> I. <br><b>CStone Pharmaceuticals<\/b> I. <br><b>Cirina Ltd<\/b> I. <br><b>Covidien LP<\/b> I. <br><b>Curio Science<\/b> I. <br><b>D3 Bio<\/b> I, S, S. <br><b>Da Volterra<\/b> I. <br><b>Daiichi Sankyo Company<\/b> I, T. <br><b>Daz Group<\/b> I. <br><b>Eisai<\/b> I. <br><b>Elevation Oncology<\/b> I. <br><b>Eli LIlly<\/b> I. <br><b>F. Hoffmann-La Roche Ltd<\/b> I. <br><b>Fishawack Facilitate Ltd<\/b> I. <br><b>Foundation One<\/b> I. <br><b>G1 Therapeutics Inc<\/b> I. <br><b>GLG’s Healthcare<\/b> I. <br><b>Genentech<\/b> I. <br><b>Gilead Sciences, Inc.<\/b> I. <br><b>Gritstone Oncology, Inc<\/b> I. <br><b>Guardant Health<\/b> I. <br><b>Hengrui Therapeutics Inc<\/b> I. <br><b>HutchMed<\/b> I, S. <br><b>IQVIA<\/b> I. <br><b>Ignyta, Inc<\/b> I. <br><b>Illumina, Inc.<\/b> I. <br><b>Imagene AI Ltd<\/b> I. <br><b>Incyte Corporation<\/b> I. <br><b>Inivata<\/b> I. <br><b>Insighta<\/b> S. <br><b>Janssen Pharmaceuticals<\/b> I. <br><b>Lakeshore Biotech Ltd<\/b> I, S. <br><b>Liangyihui<\/b> T. <br><b>Loxo-oncology<\/b> I, S. <br><b>Lucence Health Inc<\/b> I. <br><b>Lunit Inc<\/b> S. <br><b>Medtronic<\/b> I. <br><b>Merck Serono<\/b> I. <br><b>Merck Sharp and Dohme<\/b> I. <br><b>MiRXES<\/b> I, T. <br><b>Mirati Therapeutics Inc<\/b> I. <br><b>Novartis<\/b> I, T. <br><b>Novocure GmbH<\/b> I. <br><b>OSE Immunotherapeutics<\/b> I. <br><b>Omega Therapeutics Inc<\/b> I. <br><b>OrigiMed<\/b> I. <br><b>PeerVoice<\/b> I. <br><b>Pfizer<\/b> I, T. <br><b>Phanes Therapeutics, Inc<\/b> S. <br><b>Physicians’ Education Resource<\/b> I. <br><b>PrIME Oncology<\/b> I. <br><b>Prenetics<\/b> I, S. <br><b>Puma Biotechnology Inc<\/b> I. <br><b>Qiming Development (HK) Ltd<\/b> I. <br><b>Regeneron Pharmaceuticals Inc<\/b> I. <br><b>Roche<\/b> T. <br><b>Roche Diagnostics GmbH<\/b> I. <br><b>SFJ Pharmaceutical Ltd<\/b> I. <br><b>Sanofi-Aventis<\/b> I. <br><b>Shanghai Promedican Pharmaceuticals Co., Ltd.<\/b> I. <br><b>Simcere of America Inc.<\/b> I. <br><b>Summit Therapeutics Sub, Inc<\/b> I. <br><b>Synergy Research<\/b> I. <br><b>Taiho Pharmaceutical Co. Ltd<\/b> I. <br><b>Takeda Oncology<\/b> I. <br><b>Takeda Pharmaceuticals HK Ltd<\/b> I. <br><b>Tigermed<\/b> I. <br><b>Touch Independent Medical Education Ltd<\/b> I. <br><b>Vertex Pharmaceuticals<\/b> I. <br><b>Virtus Medical Group<\/b> I, S. <br><b>XENCOR, Inc<\/b> I. <br><b>Yuhan Corporation<\/b> I. <br><b>Zai Lab<\/b> T. <br><b>geneDecode Co., Ltd<\/b> I.","End":"4\/9\/2024 1:25:00 PM","HasWebcast":null,"Highlights":[],"Id":"609","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Tony Mok","PresenterKey":"41bc7f69-1c68-42d2-8aed-a78fe13f57f0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Tackling drug resistance to molecular targeted therapy for never smoker","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024 12:30PM","SessionId":"125","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Deciphering Lung Cancer in Non-smokers - Dedicated to the Memory of Richard H. Creech","ShowChatLink":"false","Start":"4\/9\/2024 1:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Tackling drug resistance to molecular targeted therapy for never smoker","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>A. McGarry Houghton<\/i><\/u><\/presenter>. Fred Hutchinson Cancer Research Center, Seattle, WA","CSlideId":"","ControlKey":"793ec5a0-0be3-4e29-bf18-48f84235ce77","ControlNumber":"8995","DisclosureBlock":"&nbsp;<b>A. Houghton, <\/b> None.","End":"4\/9\/2024 1:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"442","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"A. McGarry Houghton, MD","PresenterKey":"3d88fe49-1c8e-43e9-bac2-5307ea8a9c62","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Rational approach to development of Immunotherapy for never smoker","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024 12:30PM","SessionId":"125","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Deciphering Lung Cancer in Non-smokers - Dedicated to the Memory of Richard H. Creech","ShowChatLink":"false","Start":"4\/9\/2024 1:25:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Rational approach to development of Immunotherapy for never smoker","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":". ","CSlideId":"","ControlKey":"da02b2a5-a8e4-478e-b203-99dee4a454d3","ControlNumber":"9218","DisclosureBlock":"","End":"4\/9\/2024 2:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"613","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"General Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024 12:30PM","SessionId":"125","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Deciphering Lung Cancer in Non-smokers - Dedicated to the Memory of Richard H. Creech","ShowChatLink":"false","Start":"4\/9\/2024 1:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"General Discussion","Topics":null,"cSlideId":""}]